Perspective Therapeutics, Inc. Common Stock — Cash Flow (NYSE:CATX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -2.84 M-7.71 M-36.91 M-18.29 M-82.48 M -93.07 M Cash from investing activities -410 K-284 K24.37 M-218.93 M41.23 M -52.01 M Cash from financing activities 64.68 M56 K785 K289.38 M10.3 M 164.71 M Free cash flow -2.84 M-7.71 M-36.91 M-18.29 M-95.23 M -121.19 M

News

Profound Medical (PROF) Q2 Earnings Surpass Estimates

Are Medical Stocks Lagging Perspective Therapeutics, Inc. (CATX) This Year?

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Perspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?

4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

Perspective Therapeutics, Inc. (CATX) Shareholder/Analyst Call - Slideshow (NYSE:CATX) 2026-05-04

Perspective Therapeutics - Decent Prospect In Radiopharmaceuticals Field (NYSE:CATX)

Truist reiterates Buy on Perspective Therapeutics stock

RBC cuts Perspective Therapeutics stock price target on model updates

Perspective Therapeutics stock rating reiterated at Buy by BTIG

Oppenheimer reiterates Perspective Therapeutics stock rating at Outperform